CWM
ALXN

Concert Wealth Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Concert Wealth Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,866
Closed -$229K – 520
2016
Q4 		$229K Sell
1,866
-2,041
-52% -$250K 0.05% 428
2016
Q3 		$477K Buy
3,907
+543
+16% +$69.9K 0.06% 379
2016
Q2 		$396K Buy
3,364
+1,791
+114% +$254K 0.05% 392
2016
Q1 		$220K Buy
1,573
+342
+28% +$50.2K 0.03% 563
2015
Q4 		$234K Buy
+1,231
New +$215K 0.03% 548
2015
Q3 		– Sell
-2,093
Closed -$378K – 751
2015
Q2 		$378K Buy
+2,093
New +$361K 0.05% 430
2015
Q1 		– Sell
-1,917
Closed -$354K – 648
2014
Q4 		$354K Buy
+1,917
New +$355K 0.05% 403

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return